Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Francois Baclesse
With
National Cancer Institute, France
Sanofi
Age
66–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patient(e) aged over 65 years
Non metastatic breast cancer
Adjuvant chemotherapy Breast cancer: FEC, including Docetaxel Protocols
No major cognitive impairment
Lack of personality disorders and psychiatric disorders evolutionary
Having signed the informed consent of study participation
Patient(e) aged over 65 years
Breast cancer
Patients receiving no adjuvant chemotherapy
No major cognitive impairment
Lack of personality disorders and psychiatric disorders evolutionary
Having signed the informed consent of study participation
Matching on age, sex, cultural level and tumor location
You may not be if
Metastatic
Cancer primitive other than breast
Patients under 65 years
Patients with adjuvant chemotherapy is associated with targeted therapy
Patients who have received other cancer treatments (chemotherapy or radiotherapy brain)
disorders of higher functions existing in the administration of chemotherapy
Pathology psychiatric evolutionary
Refusal of participation
Patients unable to meet the cognitive tests
Drug use
Heavy drinking
Clareo Health | Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or Colon
